An observational study in Postoperative Atrial Fibrillation and Strains, sponsored by Centre Hospitalier Universitaire, Amiens. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-28.
Sponsored by Centre Hospitalier Universitaire, Amiens · Observational
Among 29 studies in Sprains and Strains with a site in France — 7 open to participants now, 8 under way, none of them phase 3. Sprains and Strains · France.
Among the 29 studies in Sprains and Strains with a site in France, this one is the 5th largest by planned enrollment of the 16 observational ones that give a count, is one of 2 that started in 2023, is one of 16 observational ones, and was the 24th registered.
246 studies on the registry are indexed under Sprains and Strains; 49 are open to participants now.
Browse Sprains and Strains studies →7 of the 29 studies in Sprains and Strains with a site in France are open now. Recruiting first, the newest first:
University Hospital, Angers · Sites in France
Ages 18+
Assistance Publique - Hôpitaux de Paris · Sites in France
Healthy volunteers
Centre Hospitalier Universitaire, Amiens · Sites in France
Ages 18+
Association Clinique Thérapeutique Infantile du val de Marne · Sites in France
Ages 1 days–17 yrs
Centre Hospitalier Universitaire de Saint Etienne · Sites in France
Ages 18–60
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 36 Sprains and Strains studies recruiting now, 13 (36%) set no upper age limit and 20 (56%) stop at 75 or younger; 7 take children under 18; 9 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
29 studies; the count open now beside each. This study's row is marked.
First in 2001; this study’s year is marked. 2 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 334 is above the median of 101 across 79 observational studies indexed under Sprains and Strains.
Median enrollment 64 across the 13 interventional studies, 101 across the 16 observational. Of the 17 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 29 have an industry lead sponsor. The 10 most frequent:
Centre Hospitalier Universitaire, Amiens is the lead sponsor of 586 studies on the registry; 185 are open to participants now.
Centre Hospitalier Universitaire, Amiens has 4 studies filed under Sprains and Strains — fewer than ten, so there is no comparison to draw.
2 of the studies in Sprains and Strains with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07028476University Hospital, AngersNew Care Pathway Using Automated Dynamic Laximetry | 2027-03 |
| NCT06009731Centre Hospitalier Universitaire, AmiensDiaphragmatic Speckle Tracking During Spontaneous Breathing Trial | 2027-06 |
Add all 2 to your calendar (.ics) → With an account.
Among the 29 studies in Sprains and Strains with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The incidence of postoperative atrial fibrillation (POAF) after cardiac surgery is around 30%. POAF increases the risk of developing permanent atrial fibrillation and raises the risk of cardiac decompensation, stroke, acute myocardial infarction, and death. While the role of the left atrium (LAF) in the pathophysiology of POAF is now well-established, the part of the right atrium (RA) remains poorly understood. Recent studies suggest a correlation between RA function and POAF.
RA function can be assessed by transthoracic echocardiography (TTE) with dedicated software for measuring the RA strain (RAS). RA function is thus divided into three phases: reservoir (RASr), conduit, and contraction. Numerous studies have demonstrated that a significant alteration in RAS predicts POAF in various clinical contexts. Therefore, it is essential to investigate whether alterations in RA function assessed by 2D-STE (RAS) are associated with an increased occurrence of FAPO after cardiac surgery.
It is essential to investigate whether alterations in RA function assessed by 2D-STE (RAS) are associated with an increased occurrence of FAPO after cardiac surgery.
This prospective, single-center study was conducted at the Amiens University Hospital. As an additional procedure to the patient's management, it includes the systematic performance of a TTE the day before the surgery, with the acquisition of specific views to measure RAS. After enrollment, the principal investigator will perform a TTE to measure RASr on particular views. TTE will be performed in a supine position at the patient's bedside by a trained medical operator, following a standardized protocol. After surgery, the patient will be monitored by a 5-lead ECG to diagnose POAF. The maximum duration of POAF monitoring will be seven days in the intensive care unit.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.
LVEF (left ventricular ejection fraction)
The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Correlation of RASr parameter variation with POAF incidence
Correlation of RASr parameter variation with POAF incidence in patients undergoing postoperative cardiac surgery
Time frame: 30 months
Plan to share: No
No publications or documents are linked to this record.
Started Oct 2023 (actual). Primary completion is estimated for Oct 2026, 36 months after the start.
Of 36 observational studies under Sprains and Strains, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 36. This study's planned 36 months is above that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Universitaire, Amiens →